Literature DB >> 8705911

Supplementary statement on hepatitis A prevention. Laboratory Centre for Disease Control.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8705911      PMCID： PMC1487981     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Safety and immunogenicity of hepatitis A vaccine in healthy children.

Authors:  Y C Horng; M H Chang; C Y Lee; A Safary; F E Andre; D S Chen
Journal:  Pediatr Infect Dis J       Date:  1993-05       Impact factor: 2.129

2.  Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children.

Authors:  K B Balcarek; M R Bagley; R F Pass; E R Schiff; D S Krause
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

Review 3.  Clinical experience with an inactivated hepatitis A vaccine.

Authors:  R Clemens; A Safary; A Hepburn; C Roche; W J Stanbury; F E André
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

4.  Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin.

Authors:  M S Green; D Cohen; Y Lerman; M Sjogren; L N Binn; S Zur; R Slepon; G Robin; C Hoke; W Bancroft
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.